Cancer mortality
is increasing at an alarming rate across
the globe.
Albeit, many therapeutics are available commercially, they are not
effective and have no cure up to today. Moreover, the knowledge gap
in cancer therapy persists, representing a potential blind spot for
the innovation of effective anticancer therapeutics. This review presents
an update on current advancements in nanopeptide therapeutics. Herein,
a detailed exploration of peptide-functionalized nanoparticles for
the development of nanotherapeutics was carried out. Different approaches
that include self-assembly nanostructures, solid phase peptide synthesis,
ligand exchange, chemical reduction, and conjugation methods for assembling
peptides for functionalizing nanodrugs are also highlighted. An outlook
on biomedical applications is also reviewed. Additionally, a comprehensive
discussion on targeted cancer cell therapy and mechanism of action
are provided. The present review reflects the functional novelty of
nanodrugs to improve stability, accessibility, bioavailability, and
specificity toward cancerous cells. Finally, it summarizes the current
challenges and future perspectives on the formulation of these nanodrugs.